Quick10K

Regenerx

Market

Closing Price ($)	Shares Out (MM)	Market Cap ($MM)
$0.17	132	$22

Financial Filings

10-Q	2019-09-30	Quarter: 2019-09-30
10-Q	2019-06-30	Quarter: 2019-06-30
10-Q	2019-03-31	Quarter: 2019-03-31
10-K	2018-12-31	Annual: 2018-12-31
10-Q	2018-09-30	Quarter: 2018-09-30
10-Q	2018-06-30	Quarter: 2018-06-30
10-Q	2018-03-31	Quarter: 2018-03-31
10-K	2017-12-31	Annual: 2017-12-31
10-Q	2017-09-30	Quarter: 2017-09-30
10-Q	2017-06-30	Quarter: 2017-06-30
10-Q	2017-03-31	Quarter: 2017-03-31
10-K	2016-12-31	Annual: 2016-12-31
10-Q	2016-09-30	Quarter: 2016-09-30
10-Q	2016-06-30	Quarter: 2016-06-30
10-Q	2016-03-31	Quarter: 2016-03-31
10-K	2015-12-31	Annual: 2015-12-31
10-Q	2015-09-30	Quarter: 2015-09-30
10-Q	2015-06-30	Quarter: 2015-06-30
10-Q	2015-03-31	Quarter: 2015-03-31
10-K	2014-12-31	Annual: 2014-12-31
10-Q	2014-09-30	Quarter: 2014-09-30
10-Q	2014-06-30	Quarter: 2014-06-30
10-Q	2014-03-31	Quarter: 2014-03-31
10-K	2013-12-31	Annual: 2013-12-31

Current Reports

8-K	2019-09-27	Shareholder Vote
8-K	2019-02-27	Enter Agreement, Off-BS Arrangement, Sale of Shares, Shareholder Rights, Other Events, Exhibits
8-K	2018-06-13	Shareholder Vote
8-K	2018-04-24	Other Events, Exhibits
8-K	2018-03-02	Enter Agreement, Sale of Shares, Other Events, Exhibits

Regenerx Financials

RGRX Metrics, Comps, Filings

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM)	Market Cap	Assets	Liabilities	Revenue	Gross Profit	Net Income	EBITDA	EV
Silver Bull Resources (SVBL)	18,906	10,243	590	0	0	-4,085	-4,079	16,471
GB Sciences (GBLX)	48,125	30,023	12,867	3,613	444	-23,692	-17,003	48,419
Znergy (ZNRG)	23,572	1,025	1,831	1,222	173	-3,443	-3,234	23,566
Provectus Biopharmaceuticals (PVCT)	23,094	2,718	23,684	0	0	-7,105	-6,028	21,770
H/Cell Energy (HCCC)	5,716	3,790	2,486	5,472	1,898	-706	-252	5,459
NightFood (NGTF)	34,438	460	2,043	431	241	-4,002	-4,002	34,400
Cell Medx (CMXC)		191	1,963	0	0	-899	-882	-57
Powerbridge Technologies (PBTS)	24,514	27,768	21,342	0	0	0	0	19,495
Regenerx (RGRX)	24,986	1,264	3,020	77	0	-1,361	-1,286	23,816
Aradigm (ARDM)	17,655	3,758	27,220	4,380	0	-12,780	-8,487	45,703
Cell Source (CLCS)	14,564	80	5,233	0	0	-3,376	-3,355	14,536
theGlobe.com (TGLO)	30,904			0	0	-222	-222	30,834
Determine (DTRM)	3,962	39,040	44,189	18,452	11,660	-13,472	-9,038	-2,310
Parkervision (PRKR)	20	4,626	33,312	55	-1,091	-15,741	-14,534	2,722
Regional Brands (RGBD)		30,912	12,598	38,946	11,054	702	1,512	-5,316
Dynaresource (DYNR)	20,160	10,948	7,194	7,629	0	-1,952	-1,754	20,323
Rego Payment Architectures (RPMT)	21,527	635	21,586	81	0	-3,784	-3,049	24,217
Fision (FSSN)	7,119	2,075	4,671	517	431	-5,832	-5,741	7,604
Heritage Global (HGBL)	19,600	22,984	13,131	25,009	0	2,883	3,281	15,849
Central Federal Bancshares (CFDB)	21,504	69,041	43,820	0	0	35	399	16,775

Balance Sheet ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Cash	116	136	30	32	142	235	6	177	6	1,300	675	1,241	844	1,062	563	660	318	80	1,609	1,061	769	484	243	191	182	924	663	396	237	663	1,171
Accounts Receivable	214	100	228	40	177	0	0	0	0
Inventory
PP&E	17	15	13	11	9	8	7	5	4	3	3	13	13	12	12	11	11	10	9	8	7	6	6	5	4	3	3	2	1	1	0
Assets	384	286	308	109	357	263	26	202	43	1,359	763	1,322	949	1,132	636	711	358	114	1,649	1,202	862	541	291	224	227	955	712	442	281	750	1,264
Accounts Payable	452	544	683	507	637	647	635	542	577	550	360	314	233	261	215	162	141	175	160	91	76	69	63	50	66	70	39	32	92	39	58
Long-Term Debt
Liabilities	811	1,085	1,218	1,078	1,380	1,598	1,572	1,827	1,664	3,521	3,117	2,528	2,661	4,534	5,682	6,842	7,101	10,063	9,119	7,744	6,929	6,432	6,000	6,254	4,343	2,903	2,968	2,446	2,493	2,707	3,020
Stockholders' Equity	-427	-799	-910	-969	-1,023	-1,336	-1,546	-1,624	-1,621	-2,163	-2,355	-1,206	-1,712	-3,402	-5,046	-6,131	-6,742	-9,950	-7,470	-6,542	-6,067	-5,891	-5,709	-6,030	-4,116	-1,948	-2,256	-2,004	-2,212	-1,957	-1,756

Income Statement ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Revenue														40	5	6	10	55	13	13	13	13	13	14	17	19	13	19	19	19	19
Cost of Revenue
Gross Profit
R&D		257	488	229		91	62	11	22	75	213	93	52	36	78	49	41	103	60	50	24	35	34	39	36	19	19	27	17	15	26
SG&A
Tax																														0	0
Net Income		-429	-226	-94		-332	-230	-100	-9	-2,125	-219	123	-533	-1,719	-1,762	-1,130	-660	-3,379	2,324	862	422	109	118	-1,359	1,417	-986	-368	-376	-264	-332	-388

Cash Flow ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Cash Operating		19	-106	2		-132	-229	-250	-170	-261															-70	-202	-261	-267	-159	-340	-267
Cash Investing				0
Cash Financing				0		225	0	421	0	1,555															60	944	0	0	0	766	775